ClinicalTrials.Veeva

Menu

Effect of Sensory Integration in Diplegic Cerebral Palsy

H

Halic University

Status

Completed

Conditions

Diplegic Cerebral Palsy

Treatments

Other: Neurodevelopmental Treatment Group
Other: Sensory Integration Therapy Group

Study type

Interventional

Funder types

Other

Identifiers

NCT06462859
HalicU-FTR-ACP-01

Details and patient eligibility

About

The purpose of this study is to compare the effects of sensory integration therapy (SIT) applied in addition to neurodevelopmental treatment (NDT) on Motor Function, Balance, and Trunk Control in diplegia cerebral palsy

Full description

Cerebral palsy is the most frequent motor disability affecting children. The condition is characterized by problems with postural control and balance, which are due to the central nervous system being compromised by a brain lesion.

In sensory processing, the steps include receiving, organizing, and interpreting sensory information, followed by generating an appropriate response. Children develop motor skills through sensory experiences. Sensory integration therapy leads to enhanced body awareness, motor planning abilities, and coordination between both sides of the body.

Literature studies have demonstrated the effectiveness of sensory integration therapy in improving motor functions in children with diplegia type CP. However, there is a notable lack of research on how sensory integration therapy, in addition to neurodevelopmental treatment (NDT), affects balance and trunk control in these children. This study aims to bridge this gap by evaluating the impact of sensory integration therapy on gross motor function, balance, and trunk control in children with diplegia type CP when used as an adjunct to NDT.

Enrollment

20 patients

Sex

All

Ages

4 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants must be between the ages of 4 and 17.
  • Participants must be classified as Level II, III, or IV according to the Gross Motor Function Classification System (GMFCS).

Exclusion criteria

  • Participants who had previously received sensory integration therapy, - Undergone Botulinum Toxin-A injections, or surgical interventions in the past year.
  • Participants who were using pharmacological agents affecting muscle tone.
  • Participants with an uncontrolled history of epilepsy.
  • Participants who were unable to attend the study regularly.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups

The experimental group
Experimental group
Description:
The experimental group received sensory integration therapy in addition to the NDT program.Both groups participated in NDT sessions for 45 minutes, three times a week, over a span of 8 weeks.
Treatment:
Other: Neurodevelopmental Treatment Group
Other: Sensory Integration Therapy Group
Control Group
Other group
Description:
The NDT program was customized for each child, incorporating a unique blend of static and dynamic balance exercises, coordination exercises, mobility exercises, and strength training exercises.Both groups participated in NDT sessions for 45 minutes, three times a week, over a span of 8 weeks.
Treatment:
Other: Neurodevelopmental Treatment Group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems